Noninvasive mechanical ventilation as a palliative treatment of acute respiratory failure in patients with end-stage solid cancer

2004 ◽  
Vol 18 (7) ◽  
pp. 602-610 ◽  
Author(s):  
Annamaria Cuomo ◽  
Monica Delmastro ◽  
Piero Ceriana ◽  
Stefano Nava ◽  
Giorgio Conti ◽  
...  
2015 ◽  
Vol 9 (1) ◽  
pp. 120-126 ◽  
Author(s):  
V Hidalgo ◽  
C Giugliano-Jaramillo ◽  
R Pérez ◽  
F Cerpa ◽  
H Budini ◽  
...  

Physiotherapist in Chile and Respiratory Therapist worldwide are the professionals who are experts in respiratory care, in mechanical ventilation (MV), pathophysiology and connection and disconnection criteria. They should be experts in every aspect of the acute respiratory failure and its management, they and are the ones who in medical units are able to resolve doubts about ventilation and the setting of the ventilator. Noninvasive mechanical ventilation should be the first-line of treatment in acute respiratory failure, and the standard of care in severe exacerbations of chronic obstructive pulmonary disease, acute cardiogenic pulmonary edema, and in immunosuppressed patients with high levels of evidence that support the work of physiotherapist. Exist other considerations where most of the time, physicians and other professionals in the critical units do not take into account when checking the patient ventilator synchrony, such as the appropriate patient selection, ventilator selection, mask selection, mode selection, and the selection of a trained team in NIMV. The physiotherapist needs to evaluate bedside; if patients are properly connected to the ventilator and in a synchronously manner. In Chile, since 2004, the physioterapist are included in the guidelines as a professional resource in the ICU organization, with the same skills and obligations as those described in the literature for respiratory therapists.


2010 ◽  
Vol 13 (2) ◽  
pp. E91-E95 ◽  
Author(s):  
Erich Kilger ◽  
Patrick Möhnle ◽  
Kirsten Nassau ◽  
Andres Beiras-Fernandez ◽  
Peter Lamm ◽  
...  

1991 ◽  
Vol 35 (1) ◽  
pp. 33
Author(s):  
M. W. ELLIOTT ◽  
M. H. STEVEN ◽  
G. D. PHILLIPS ◽  
M. A. BRANTHWAITE

2017 ◽  
Vol 9 (1) ◽  
Author(s):  
Hiroshi Kataoka ◽  
Hitoki Nanaura ◽  
Kaoru Kinugawa ◽  
Yuto Uchihara ◽  
Hiroya Ohara ◽  
...  

If invasive ventilation can be avoided by performing noninvasive mechanical ventilation (NIV) in patients with acute respiratory failure (ARF), the disease can be effectively managed. It is important to clarify the characteristics of patients with neuromuscular diseases in whom initial NIV is likely to be unsuccessful. We studied 27 patients in stable neuromuscular condition who initially received NIV to manage fatal ARF to identify differences in factors immediately before the onset of ARF among patients who receive continuous NIV support, patients who are switched from NIV to invasive ventilation, and patients in whom NIV is discontinued. Endpoints were evaluated 24 and 72 hours after the initiation of NIV. After 24 hours, all but 1 patient with amyotrophic lateral sclerosis (ALS) received continuous NIV support. 72 hours later, 5 patients were switched from NIV to invasive ventilation, and 5 patients continued to receive NIV support. 72 hours after the initiation of NIV, the proportion of patients with a diagnosis of ALS differed significantly among the three groups (P=0.039). NIV may be attempted to manage acute fatal respiratory failure associated with neuromuscular diseases, but clinicians should carefully manage the clinical course in patients with ALS.


Sign in / Sign up

Export Citation Format

Share Document